Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
The current price of BIO is $297.43 USD — it has increased by +1.27% in the past 24 hours. Watch Bio-Rad Laboratories stock price performance more closely on the chart.
What is Bio-Rad Laboratories stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Bio-Rad Laboratories stocks are traded under the ticker BIO.
Is Bio-Rad Laboratories stock price growing?▼
BIO stock has fallen by -0.62% compared to the previous week, the month change is a -2.57% fall, over the last year Bio-Rad Laboratories has showed a -17.58% decrease.
When is the next Bio-Rad Laboratories earnings date?▼
Bio-Rad Laboratories is going to release the next earnings report on February 12, 2026.
What were Bio-Rad Laboratories earnings last quarter?▼
BIO earnings for the last quarter are 2.26 USD per share, whereas the estimation was 1.95 USD resulting in a +15.66% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Bio-Rad Laboratories revenue for the last year?▼
Bio-Rad Laboratories revenue for the last year amounts to 5.13B USD.
What is Bio-Rad Laboratories net income for the last year?▼
BIO net income for the last year is -3.69B USD.
How many employees does Bio-Rad Laboratories have?▼
As of February 02, 2026, the company has 7,700 employees.
In which sector is Bio-Rad Laboratories located?▼
Bio-Rad Laboratories operates in the Health Care sector.
When did Bio-Rad Laboratories complete a stock split?▼
The last stock split for Bio-Rad Laboratories was on March 08, 2002 with a ratio of 2:1.
Where is Bio-Rad Laboratories headquartered?▼
Bio-Rad Laboratories is headquartered in Hercules, US.